LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

Search

ACADIA Pharmaceuticals Inc

Fermé

Secteur Soins de santé

17.79 0.79

Résumé

Variation du prix de l'action

24h

Actuel

Min

17.68

Max

17.83

Chiffres clés

By Trading Economics

Revenu

-29M

17M

Ventes

-25M

206M

BPA

0.1

Marge bénéficiaire

8.044

Employés

597

EBITDA

-16M

21M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+54.19 upside

Dividendes

By Dow Jones

Prochains Résultats

31 juil. 2024

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-6.6M

2.7B

Ouverture précédente

17

Clôture précédente

17.79

Sentiment de l'Actualité

By Acuity

100%

0%

347 / 369 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

ACADIA Pharmaceuticals Inc Graphique

Actualités Associées

12 juil. 2024, 22:05 UTC

Acquisitions, Fusions, Rachats

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110 Million

12 juil. 2024, 20:18 UTC

Acquisitions, Fusions, Rachats

Lundin Mining Approaches BHP to Buy Copper Miner Filo, Bloomberg Reports

12 juil. 2024, 19:57 UTC

Principaux Mouvements du Marché

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

12 juil. 2024, 18:13 UTC

Actualités

Elon Musk's X Found in Breach of EU Digital-Content Law -- 2nd Update

13 juil. 2024, 12:00 UTC

Actualités

Rate Cuts Could Make Things Worse for Banks Before They Help -- Heard on the Street -- WSJ

13 juil. 2024, 01:19 UTC

Actualités

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- 3rd Update

12 juil. 2024, 23:29 UTC

Acquisitions, Fusions, Rachats

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

12 juil. 2024, 21:50 UTC

Acquisitions, Fusions, Rachats

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110M

12 juil. 2024, 21:03 UTC

Actualités
Acquisitions, Fusions, Rachats

The Score: Microsoft, Delta Air Lines, Wells Fargo and More Stocks That Defined the Week -- WSJ

12 juil. 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 juil. 2024, 20:41 UTC

Actualités

Dow Rises With Investors Putting Rate Cut in Sight -- WSJ

12 juil. 2024, 20:38 UTC

Acquisitions, Fusions, Rachats

Ansys: Synopsys Submits Notification of Transaction to China Regulator for Purchase of Ansys

12 juil. 2024, 20:26 UTC

Actualités
Résultats

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12 juil. 2024, 20:19 UTC

Résultats

These Stocks Moved the Most Today: Tesla, Wells Fargo, JPMorgan, BNY, Nvidia, and More -- Barrons.com

12 juil. 2024, 19:26 UTC

Résultats

Correction to Big Banks Continue to Feel Pressure From Higher Rates Article -- WSJ

12 juil. 2024, 19:07 UTC

Market Talk

U.S. Natural Gas Futures Snap 3-Day Losing Streak -- Market Talk

12 juil. 2024, 17:52 UTC

Actualités
Résultats

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12 juil. 2024, 17:34 UTC

Market Talk

Gold Takes Pause After Surge -- Market Talk

12 juil. 2024, 17:31 UTC

Market Talk

U.S. Oil Rig Count Down By 1 to 478 -- Market Talk

12 juil. 2024, 17:22 UTC

Market Talk

Private-Capital Investing For Solar Developers Dropped in 1H -- Market Talk

12 juil. 2024, 17:01 UTC

Actualités

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- 2nd Update

12 juil. 2024, 16:45 UTC

Market Talk

Nike's Corporate Plan Step in Right Direction, but Challenges Mount -- Market Talk

12 juil. 2024, 16:44 UTC

Market Talk

Estée Lauder CFO Change Needs to Offer Fresh Perspective -- Market Talk

12 juil. 2024, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

12 juil. 2024, 16:08 UTC

Market Talk

Gold Futures Pare Some Gains But Hold Above $2,400 on Soft Inflation Data -- Market Talk

12 juil. 2024, 16:02 UTC

Actualités

Big Banks Continue to Feel Pressure From Higher Rates -- 2nd Update

12 juil. 2024, 15:45 UTC

Market Talk

KC Fed Seeing Green Shoots in Energy Activity -- Market Talk

12 juil. 2024, 15:43 UTC

Market Talk

Bank of Canada Likely Thrilled With Housing-Market Data -- Market Talk

12 juil. 2024, 15:39 UTC

Market Talk

Canada Home-Sales Activity 'Subdued' Despite Rise in June -- Market Talk

12 juil. 2024, 15:36 UTC

Actualités

Berkshire Hathaway Stock Hits Record. Warren Buffett's Stake at $133 Billion. -- Barrons.com

Comparaison

Variation de prix

ACADIA Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

54.19% hausse

Prévisions sur 12 Mois

Moyen 27.4 USD  54.19%

Haut 39 USD

Bas 17 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

15 ratings

11

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

15.89 / 17.96Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).